Eli Lilly, Amgen Partner to Advance COVID-19 Antibody Therapies
Early Data Shows Promise for Johnson & Johnson’s COVID-19 Vaccine
Bristol Myers Squibb Reports Breakthrough with Immunotherapy Opdivo
Gilead to Pay $97M to Resolve Healthcare Fraud Allegations
FDA Finalizes Rule on Prescription Drug Importation from Canada
Bristol Myers Squibb Gets FDA Priority Review for T-Cell Therapy
Exploring the Most Favored Nation Approach for Drug Pricing
FDA Seeks to Clarify Evidence for Intended Use Determinations
J&J Initiates Global Phase 3 Clinical Trial for COVID-19 Vaccine
Global Effort Aims to Insure Against a Failed COVID-19 Vaccine
GSK, Sanofi to Supply 300M Doses of COVID-19 Vaccine to EU
Roche Launches Quantitative COVID-19 Antibody Test
Just Half of Americans Would Get a COVID-19 Vaccine If Ready Today
Immunotherapy Combo from Bristol Myers Squibb Improves Survival
HHS, DoD Release COVID-19 Vaccine Distribution Strategy
Bolstering the Pharmaceutical Supply Chain for a COVID-19 Vaccine
Prices of Brand Name Migraine Medications Continue to Increase
Brand Drug Product Hopping Costs US $4.7B Annually
Gauss, Cellex Launch First At-Home COVID-19 Antigen Test
Medicare Switches to Generic Cholesterol Drugs and Saves Billions
HHS Issues Guidance to Expand Access to COVID-19 Vaccines
J&J COVID-19 Vaccine Shows Promise in Preclinical Trial
Trump Pursues Most Favored Nation Strategy for Lower Drug Prices
Promoting Health Equity in COVID-19 Vaccine Clinical Trials
Systemic Corticosteroids Linked to Lower COVID-19 Mortality
Steps to Implement a Successful COVID-19 Vaccination Program
New Study Expounds Harms of Drug Rebates on Patients, Healthcare
Mylan, Biocon Biologics Launch Diabetes Biosimilar in the US
FDA Authorizes Faster COVID-19 Antigen Test from Abbott
Eli Lilly’s Diabetes Drug Jardiance Helps Heart Failure, Too
CEOs Pledge to Uphold Scientific Integrity for COVID-19 Vaccine
Breaking Down the Stages of Clinical Trials, Their Challenges
NIH Challenges Use of Convalescent Plasma to Treat COVID-19
AstraZeneca’s COVID-19 Vaccine Enters Phase 3 Clinical Trial
National Academy of Medicine Presents COVID-19 Vaccine Framework
Pharmaceutical M&A Activity Increased 17% in First Half of 2020
GSK, Vir Dose First Patient in Phase 2/3 COVID-19 Antibody Study
FDA Expands Remdesivir Use to All Hospitalized COVID-19 Patients
How EHR-Based Clinical Trials Can Accelerate Research Strategies